For Specialized Pharmacy and Health Care Legal Services Call (720)222-1276 • Baer Law provides services to all of the United States

Client Focused. Results Driven.

Understanding where pharmacy and law intersect. Expert representation at a reasonable price

Baer Law

25521 E. Smoky Hill Road
Suite #120, Aurora, CO 80016
720.222.1276

Please enter your name.
Please enter a message.
BaerLaw_Color_Logo

About Baer Law

John brings over twenty-five combined years of experience as a pharmacist and attorney to the Baer Law Firm LLC. John's personal goal since finishing law school was to incorporate both his experiences as a clinical pharmacist and an attorney into his own, successful law practice. After obtaining his undergraduate and his Doctorate of Pharmacy (PharmD) degrees from the University of Arizona, John relocated to Colorado. He continued to work as a clinical hospital pharmacist while attending law school and obtained his Juris Doctorate (JD) at the University of Denver College of Law.

Our Legal Services

We are uniquely positioned to understand the complex needs of our diverse clients. 

PharmacyIcon

Pharmacy Law

As an expert in the field, Baer Law covers a variety of Pharmaceutical Law services ranging from Federal & State Regulatory Issues to FDA Compliance and Drug Compounding. 

Read More >

MedicalIcon

Health Care Law

Baer Law focuses on a variety of health care law services ranging from Telemedicine / Telepharmacy and HIPAA Compliance to Professional Board Actions.

Read More >

Client Testimonial

"I want to thank you again for all you have done for me.   I cannot express my gratitude to you and the time and effort you put into my case.   You truly care and I wanted to thank you again for everything."

FDA's Guidance on Compounding for Human Use

As discussed previously on the Baer Law Blog, Title I of the Drug Quality and Security Act (DQSA) gives the Food and Drug Administration (FDA) new powers to oversee drug compounding. Section 503A of the DQSA sets out certain requirements for traditional compounding, while Section 503B creates a new entity called outsourcing facilities. This blog…

Hydrocodone Combination Products Moving to Schedule II

On August 22, the Drug Enforcement Agency (DEA) published a final rule to move hydrocodone combination products (HCPs) from Schedule III to Schedule II. The change takes effect on October 6, 2014. Under the finale rule, all Schedule II requirements with respect to security, labeling and packaging, inventory, record keeping and reporting, etc., will apply to…

Disposing of Unused Controlled Substances: DEA Expands Prescription Drug Take-Back

In early October, disposing of unused medications, including controlled substances, will likely get much easier as the Drug Enforcement Agency (DEA) is expanding the options to collect medications with the hopes that the rule expansion will discourage individuals from simply flushing drugs down the toilet, throwing drugs away or leaving drugs in medicine cabinets. With…